Wang, H.; Liu, H.; Sun, C.; Liu, C.; Jiang, T.; Yin, Y.; Xu, A.; Pang, Z.; Zhang, B.; Hu, Y.
Nanoparticles Dual Targeting Both Myeloma Cells and Cancer-Associated Fibroblasts Simultaneously to Improve Multiple Myeloma Treatment. Pharmaceutics 2021, 13, 274.
https://doi.org/10.3390/pharmaceutics13020274
AMA Style
Wang H, Liu H, Sun C, Liu C, Jiang T, Yin Y, Xu A, Pang Z, Zhang B, Hu Y.
Nanoparticles Dual Targeting Both Myeloma Cells and Cancer-Associated Fibroblasts Simultaneously to Improve Multiple Myeloma Treatment. Pharmaceutics. 2021; 13(2):274.
https://doi.org/10.3390/pharmaceutics13020274
Chicago/Turabian Style
Wang, Honglan, Huiwen Liu, Chunyan Sun, Chunying Liu, Ting Jiang, Yanxue Yin, Aoshuang Xu, Zhiqing Pang, Bo Zhang, and Yu Hu.
2021. "Nanoparticles Dual Targeting Both Myeloma Cells and Cancer-Associated Fibroblasts Simultaneously to Improve Multiple Myeloma Treatment" Pharmaceutics 13, no. 2: 274.
https://doi.org/10.3390/pharmaceutics13020274
APA Style
Wang, H., Liu, H., Sun, C., Liu, C., Jiang, T., Yin, Y., Xu, A., Pang, Z., Zhang, B., & Hu, Y.
(2021). Nanoparticles Dual Targeting Both Myeloma Cells and Cancer-Associated Fibroblasts Simultaneously to Improve Multiple Myeloma Treatment. Pharmaceutics, 13(2), 274.
https://doi.org/10.3390/pharmaceutics13020274